Search filters

Filters
Clear All

Phase

  • 183
  • 152
  • 2
  • 189
  • 147
  • 17
  • 381
  • 1210
  • 580
  • 29
  • 46
  • 3
  • 1138
  • 1210
  • 6

Found 1216 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 99 years
Male
Interventional
This study involves research and is conducted to determine the safety, tolerability (how 6 your body reacts to the drug) and effectiveness of a study drug called REGN5678 which 7 will be given alone first and then be given in combination with cemiplimab.
 An Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
18 years - 99 years
All genders
Interventional
Open label extension trial of CVL-865 in adults with drug-resistant focal onset seizures to learn how well the investigational drug works and how safe it is for long-term epilepsy treatment. Participants will answer questions; undergo physical-neuro exams; vitals; ECG collection; blood draws; urine collection; questions about the study drug; and …
 ANDROMEDA-SHOCK-2 Trial
18 years - 99 years
All genders
Septic shock is a disease of the circulatory system representing a complication of serious infections, and is associated with a very high mortality, since around 1/3 of patients with this condition die. This disease produces a series of alterations in the body, including failure of the heart, kidneys, liver, among …
 Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
18 years - 99 years
All genders
Phase 3
Interventional
The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab for the treatment of participants with generalized myasthenia gravis (gMG).
18 years - 99 years
All genders
Phase 2
Interventional
The LTI-01-2001 study is a double-blind, placebo-controlled, Phase 2 study to evaluate LTI-01 (single-chain urokinase plasminogen activator, scuPA) in patients with infected, non-draining pleural effusions.
 A Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma
18 years - 120 years
All genders
Interventional
A Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma
 Study of Regn4336 administered Alone or in Combination with Cemiplimab in Patients with Metastatic Castration-Resistant Prostate Cancer
18 years - 99 years
Male
Interventional
This research study is designed to learn more about the safety and effectiveness of REGN4336 alone or in combination with cemiplimab given to individuals who have been diagnosed with Prostate Cancer.
 Emergency Department-Initiated Buprenorphine Validation Network Trial
18 years - 99 years
All genders
Interventional
The purpose of this research study is to compare two versions of the same medication buprenorphine, (commonly known as Suboxone) used to treat opioid use disorder, in patients in the Emergency Department (ED). One form of the medication is a slow-release form of buprenorphine (CAM2038) that lasts for about 7 …
 Tissue Collection for Multiple Myeloma Research
18 years - 99 years
All genders
Interventional
The primary purpose of this research study is to obtain specimens (blood, bone marrow, and other tissues) for research about multiple myeloma and related diseases.
 A Randomized Study Comparing Venetoclax and Azacitidine to Induction  Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia
18 years - 99 years
All genders
Phase 2
Interventional
This research is being done to see how an investigational combination of study drugs works in comparison to chemotherapy in people with acute myeloid leukemia. This study involves the following study drug combinations. You will only receive one of these combinations: • Venetoclax and azacitidine (investigational combination) • Cytarabine and …
411 - 420 of 1216